Project Grant P01MH139136
Award Date
6/2/25
Completion Date
5/31/30
Dollars Obligated
$1.7M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,217,886 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Feinstein Institutes for Medical Research. The goal of this 5-year project, starting on September 5, 2024, is to develop a clozapine decision support tool for first episode psychosis (FEP) patients. The tool will leverage three biomarkers - a functional brain scan, and genetic tests for weight gain and agranulocytosis risk - to predict which FEP...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to identify biomarkers in the cerebellar-cortical circuitry that can predict treatment response to antipsychotic medication in patients with early psychosis. The $519,558 award, which runs from June 2025 to April 2030, will enable the Feinstein Institutes for Medical Research to validate the identified predictive biomarker in a larger sample...
The National Institute of Mental Health (NIMH) awarded a $845,163 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Feinstein Institutes for Medical Research. The project aims to develop a low-cost, low-burden approach that produces accurate, objective markers of psychosis severity using automated speech and language analysis. This would serve as "vital signs" for monitoring psychosis in a longitudinal clinical context. The project will first build a...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is focused on leveraging electronic health records (EHRs) and genetic data to develop predictive models and identify subtypes of psychosis-related disorders. The key products and services to be delivered under this $1,424,534 award include: Building machine learning-based prediction models to forecast clinical outcomes such as treatment response, illness...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $961,668 to The Feinstein Institutes for Medical Research to leverage electronic health records, dimensional phenotyping, and genetic analyses to build predictive models and identify subtypes of clinical outcomes for individuals with schizophrenia and other psychosis-related disorders. The 5-year project aims to advance precision psychiatry by...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $720,375 to New York University School of Medicine to leverage electronic health records (EHRs) and advanced data analytics to develop predictive models and identify clinical outcome subtypes for psychosis-related disorders. The key products and services to be delivered include: Building machine learning models to forecast major prognostic outcomes...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $3,412,446 to the University of Maryland, Baltimore to leverage a two-state learning healthcare system (CLHS) and early psychosis intervention network (EPINET) hub to pursue integrated research and knowledge generation focused on optimizing coordinated specialty care (CSC) engagement and preventing disengagement in youth with first episode psychosis (FEP). The grant supports...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is supporting a multi-center, randomized clinical trial to evaluate the use of biomarkers to guide treatment decisions for first-episode psychosis (FEP) patients. The $731,452 award will fund a study to characterize 410 FEP patients using three biomarkers - a functional brain scan, and genetic tests for weight gain and agranulocytosis risk. Patients...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $389,880 to the University of North Carolina at Chapel Hill to develop and test behavioral economics and financial incentive-based strategies to improve treatment engagement, medication adherence, and substance avoidance for patients transitioning from first-episode psychosis coordinated specialty care to post-care. The 5-year award, beginning...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $434,421 to The Feinstein Institutes for Medical Research to conduct research on the development of cerebellar-cortical functional connectivity in youth and its prediction of psychosis. The key objectives of this 4-year project are to: 1) chart the normal development curves of cerebellar-cortical connectivity from childhood to early adulthood using...